Lesion T2 relaxation times and volumes predict the response of malignant breast lesions to neoadjuvant chemotherapy

Magnetic Resonance Imaging

Volumn 26, Issue 1, 2008, Pages 26-34

  Tan, P Clara ^a   Pickles, Martin D ^a   Lowry, Martin ^a   Manton, David J ^a   Turnbull, Lindsay W ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Breast cancer; Chemotherapy; Magnetic resonance imaging; Magnetic resonance spectroscopy; Water T2

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM PENTETATE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MATHEMATICAL COMPUTING; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT ASSESSMENT; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; PREDICTIVE VALUE OF TESTS; ROC CURVE; TREATMENT OUTCOME;

EID: 37349037117     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2007.04.002     Document Type: Article

References (22)

1. Wasser K., Klein S.K., Fink C., Junkermann H., Sinn H.P., Zuna I., et al. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol 13 (2003) 80-87
2. Huang Y.M., Majumdar S., Genant H.K., Chan W.P., Sharma K.R., Yu P., et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular-dystrophy. J Magn Reson Imaging 4 (1994) 59-64
3. 2 - preliminary findings at 3 T. Radiology 214 (2000) 259-266
4. 2 relaxometry: first experiences in patients with temporal lobe epilepsy. J Magn Reson Imaging 13 (2001) 547-552
5. 1H MRS and MRI. Magn Reson Imaging 15 (1997) 1177-1186
6. 2 mapping of the liver. J Magn Reson Imaging 16 (2002) 179-189
7. 2-distribution to study tumor extent and heterogeneity in head and neck-cancer. Magn Reson Imaging 9 (1991) 205-211
8. Braunschweiger P.G. Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors. Cancer Res 48 (1988) 4206-4210
9. 1ρ magnetic resonance imaging of RIF-1 tumors in vivo: detection of early response to cyclophosphamide therapy. Cancer Res 61 (2001) 7747-7753
10. Pickles M.D., Gibbs P., Lowry M., and Turnbull L.W. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24 (2006) 843-847
11. Manton D.J., Chaturvedi A., Hubbard A., Lind M., Lowry M., Maraveyas A., et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 94 (2006) 427-435
12. Partridge S.C., Esserman L.J., Newitt D.C., and Hylton N.M. Assessing the value of early MR measurements for predicting response to neoadjuvant treatment in locally advanced breast cancer. Proc ISMRM 9 (2001) 2320
13. Partridge S.C., Gibbs J.E., Lu Y., Esserman L.J., Tripathy D., Wolverton D.S., et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. Am J Roentgenol 184 (2005) 1774-1781
14. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
15. 2 mapping: application to the prostate. J Magn Reson Imaging 6 (1996) 603-607
16. Hurd R.E., Gurr D., and Sailasuta N. Proton spectroscopy without water suppression: the oversampled J-resolved experiment. Magn Reson Med 40 (1998) 343-347
17. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i (1986) 307-310
18. Denis F., Sbiez-Bourcier A.V., Chapiron C., Arbion F., Bodyd G., and Brunereau L. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol 30 (2004) 1069-1076
19. Londero V., Bazzocchi M., Del Frate C., Puglisi F., Di Loreto C., Francescutti G., et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14 (2004) 1371-1379
20. Pickles M.D., Lowry M., Manton D.J., Gibbs P., and Turnbull L.W. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 91 (2005) 1-10
21. Merchant T.E., Thelissen G.R.P., de Graaf P.W., Nieuwenhuizen C.W.E.A., Kievit H.C.E., and den Otter W. Application of a mixed imaging sequence for MR imaging characterization of human breast disease. Acta Radiol 34 (1993) 356-361
22. Jagannathan N.R., Singh M., Govindaraju V., Raghunathan P., Coshic O., Julka P.K., et al. Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR in Biomed 11 (1998) 414-422